Molecular docking studies of phytochemicals from Phyllanthus niruri against Hepatitis B DNA Polymerase
Hepatitis B virus (HBV) infection is the leading cause for liver disorders and can lead to hepatocellular carcinoma, cirrhosis and liver damage which in turn can cause death of patients. HBV DNA Polymerase is essential for HBV replication in the host and hence is used as one of the most potent pharmacological target for the inhibition of HBV. Chronic hepatitis B is currently treated with nucleotide analogues that suppress viral reverse transcriptase activity and most of them are reported to have viral resistance. Therefore, it is of interest to model HBV DNA polymerase to dock known phytochemicals. The present study focuses on homology modeling and molecular docking analysis of phytocompounds from the traditional antidote Phyllanthus niruri and other nucleoside analogues against HBV DNA Polymerase using the software Discovery studio 4.0. 3D structure of HBV DNA Polymerase was predicted based on previously reported alignment. Docking studies revealed that a few phytochemicals from Phyllanthus niruri had good interactions with HBV DNA Polymerase. These compounds had acceptable binding properties for further in vitro validation. Thus the study puts forth experimental validation for traditional antidote and these phytocompounds could be further promoted as potential lead molecule.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Bioinformation - 11(2015), 9 vom: 03., Seite 426-31 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mohan, Mekha [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Hepatitis B |
|---|
| Anmerkungen: |
Date Completed 03.11.2015 Date Revised 30.09.2020 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.6026/97320630011426 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM25427286X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM25427286X | ||
| 003 | DE-627 | ||
| 005 | 20231224172024.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.6026/97320630011426 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0847.xml |
| 035 | |a (DE-627)NLM25427286X | ||
| 035 | |a (NLM)26527851 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mohan, Mekha |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Molecular docking studies of phytochemicals from Phyllanthus niruri against Hepatitis B DNA Polymerase |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.11.2015 | ||
| 500 | |a Date Revised 30.09.2020 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Hepatitis B virus (HBV) infection is the leading cause for liver disorders and can lead to hepatocellular carcinoma, cirrhosis and liver damage which in turn can cause death of patients. HBV DNA Polymerase is essential for HBV replication in the host and hence is used as one of the most potent pharmacological target for the inhibition of HBV. Chronic hepatitis B is currently treated with nucleotide analogues that suppress viral reverse transcriptase activity and most of them are reported to have viral resistance. Therefore, it is of interest to model HBV DNA polymerase to dock known phytochemicals. The present study focuses on homology modeling and molecular docking analysis of phytocompounds from the traditional antidote Phyllanthus niruri and other nucleoside analogues against HBV DNA Polymerase using the software Discovery studio 4.0. 3D structure of HBV DNA Polymerase was predicted based on previously reported alignment. Docking studies revealed that a few phytochemicals from Phyllanthus niruri had good interactions with HBV DNA Polymerase. These compounds had acceptable binding properties for further in vitro validation. Thus the study puts forth experimental validation for traditional antidote and these phytocompounds could be further promoted as potential lead molecule | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Hepatitis B | |
| 650 | 4 | |a Homology modeling | |
| 650 | 4 | |a Molecular Docking | |
| 650 | 4 | |a Phyllanthus niruri | |
| 650 | 4 | |a Phytochemicals | |
| 700 | 1 | |a James, Priyanka |e verfasserin |4 aut | |
| 700 | 1 | |a Valsalan, Ravisankar |e verfasserin |4 aut | |
| 700 | 1 | |a Nazeem, Puthiyaveetil Abdulla |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioinformation |d 2005 |g 11(2015), 9 vom: 03., Seite 426-31 |w (DE-627)NLM171161769 |x 0973-2063 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2015 |g number:9 |g day:03 |g pages:426-31 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.6026/97320630011426 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2015 |e 9 |b 03 |h 426-31 | ||